Skip to main content
PLOS One logoLink to PLOS One
. 2024 Oct 3;19(10):e0308679. doi: 10.1371/journal.pone.0308679

Platelet activation near point-like source of agonist: Experimental insights and computational model

Ezhena S Starodubtseva 1, Tatyana Yu Karogodina 1,2, Alexander E Moskalensky 1,*
Editor: Heather Faith Pidcoke3
PMCID: PMC11449293  PMID: 39361659

Abstract

Disorders of hemostasis resulting in bleeding or thrombosis are leading cause of mortality in the world. Blood platelets are main players in hemostasis, providing the primary response to the vessel wall injury. In this case, they rapidly switch to the activated state in reaction to the exposed chemical substances such as ADP, collagen and thrombin. Molecular mechanisms of platelet activation are known, and detailed computational models are available. However, they are too complicated for large-scale problems (e.g. simulation of the thrombus growth) where less detailed models are required, which still should take into account the variation of agonist concentration and heterogeneity of platelets. In this paper, we present a simple model of the platelet population response to a spatially inhomogeneous stimulus. First, computational nodes modeling platelets are placed randomly in space. Each platelet is assigned the specific threshold for agonist, which determines whether it becomes activated at a given time. The distribution of the threshold value in a population is assumed to be log-normal. The model was validated against experimental data in a specially designed system, where the photorelease of ADP was caused by localized laser stimulus. In this system, a concentration of ADP obeys 2-dimensional Gaussian distribution which broadens due to the diffusion. The response of platelets to the point-like source of ADP is successfully described by the presented model. Our results advance the understanding of platelet function during hemostatic response. The simulation approach can be incorporated into larger computational models of thrombus formation.

Introduction

Platelets are known to be involved in many physiological processes: apart from their main hemostatic function, they also participate in immune and inflammatory responses, release growth factors and regulate angiogenesis [13]. However, the primary function of a platelet is to prevent bleeding in case of vessel wall injury. Platelets have developed a unique activation mechanism which enables fast transformation from resting, inert cells to particles eager to adhere to the damaged surface and aggregate with each other [4]. Apart from adhesion and aggregation, platelets also may release granules recruiting additional cells and provide factors promoting blood coagulation [5].

Biochemical cascade of the platelet activation involves special chemical compounds called agonists, which accumulate around the damaged area and trigger the process [6]. The agonists, such as collagen, adenosine diphosphate (ADP), epinephrine, thrombin etc., bind to the specific receptors on the platelet plasma membrane and initiate a physiological response [7, 8]. Namely, ADP induces platelet activation through the interactions with G-Protein-Coupled Receptors (GPCRs) P2Y1 and P2Y12 [9]. Both of them have an impact on phospholipase C (PLC) that leads to the release of inositol trisphosphate (IP3), which, in turn, activate fast elevation of Ca2+ in the cytoplasm of the cells [10, 11]. The rise in cytoplasmic calcium concentration is considered to be the hallmark of platelet activation.

The dynamics of cytosolic calcium concentration can be detected in real time using the fluorogenic calcium probes such as Fluo-4 [12]. Calcium spikes can even be visualized in single platelets with the fluorescent microscopy [13], which allows one to evaluate the activation of each cell. This method is suitable for investigating activation by an agonist with spatially inhomogeneous distribution, which is the case in physiological processes. Dynamic inhomogeneous distribution may arise from the diffusion of agonists from localized sources. It is of great interest since the hemostatic plug is formed by the aggregation of the activated platelets due to the diffusion of thrombin and ADP from its core [14]. In addition, granules released by activated platelets that contain additional activators acting as positive-feedback amplifiers [15, 16] also contribute to the agonist concentration profile. However, granule release usually requires high concentrations of ADP [17] and occurs in a later stage of activation [18]. Nevertheless, in order to model the clot formation, it is important to take into the account spatiotemporal distribution of the agonists; however, direct experimental observations of platelet activation in a system with inhomogeneous distribution of ADP are still lacking.

Molecular mechanisms of platelet activation are known. For instance, Purvis et al. [19] developed a detailed model which is able to predict cytosolic calcium concentration in response to the addition of ADP. Although the response of the platelet population has monotonic dependence on the agonist concentration, activation of each platelet has stochastic, threshold-like nature. Sveshnikova et al. [20] identified the decision-making element determining the activation threshold. Modeling of thrombus formation implies inhomogeneous distribution of agonists, and the activation state of each platelet should be determined [21, 22]. Additionally, both agonists and cells are non-stationary due to blood flow and diffusion [2325]. Usually, simpler models of platelet activation are used in such complex problems [2628]. Hill equation was used to describe threshold-like dependence of activation probability on the ADP concentration [29, 30]. Litvinenko et al. [31] assumed that the sensitivity of platelets to ADP has log-normal distribution. These simplified models enable complex simulations, but there is an urgent need for their experimental verification.

In this study, we present a simple computational model of the platelet population response to a spatially inhomogeneous stimulus. First, computational nodes modeling one or few platelets are placed randomly in space. Each node is assigned the specific threshold for agonist, which determines whether it becomes activated. The distribution of the threshold value in a population is assumed to be log-normal. The model is validated against experimental data in a specially designed 2-dimensional system. The platelets are activated by optically uncaging of ADP from its photolabile analogue, NPE-caged ADP. Since the photorelease of ADP is caused by localized laser stimulus, the concentration of ADP obeys 2-dimensional Gaussian distribution which broadens due to the diffusion. The developed algorithm allows us to simulate platelets population response (fraction of activated cells and average fluorescent signal) to such an inhomogeneous stimulus.

Methods

Sample preparation

The blood samples of three healthy donors (female 22yo, male 35yo and female 40yo) were obtained from the cubital vein. Written informed consent was obtained from the volunteers prior to the study. The study protocol was approved by the Ethics Committee of the research Institute of Clinical and Experimental Lymphology–Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences. The volunteers were recruited during the period from 01/09/2023 to 01/04/2024.

The samples were collected to the standard vacuum tubes containing sodium citrate as anticoagulant (9:1). After that blood sample was settled at room temperature for about one hour until a layer of platelet-rich plasma was separated from the rest of the blood cells. Centrifugation was not used. Then fluorescent calcium probe Fluo-4-AM (Thermo Fisher Scientific, USA) was added to the sample for labeling. The 1 μL of Fluo-4-AM (1 mM stock solution in DMSO) was added to 61.5 μL to phosphate buffered saline (PBS) and mixed with blood plasma in 1 to 1 proportion. After 30 minute incubation, 8 μL of the labeled cells were placed in wells of 8-well polystyrene strip plate with addition of 3 μL of caged ADP (NPE-caged-ADP, 10 mM stock solution) and 69 μL of PBS (final concentration of caged ADP is 0.375 mM). We tested out HEPES buffer instead of PBS in additional experiment, but results were controversial (S3 Fig in S1 File). After another 30 minutes the samples were used for the experiment. The height of the liquid in each sample was 2 mm.

Experimental system

For the observation of changes in platelets’ fluorescent signals during activation inverted microscope Carl Zeiss AxioVert.A1 was used. It is reported that the maximum of the fluorescence of Fluo-4 bound with Ca2+ is at the wavelength of 516 nm when it is excited with the light of a wavelength of 494 nm which corresponds with the wavelength of LED in microscope. For the purpose of detection and recording the platelet activation, a high-sensitive Axiocam 503 mono camera was used. 10X dry objective was used to observe many cells.

To locally induce the platelet activation we used a laser DTL-375QT with a wavelength of 355 nm. The laser beam was redirected into the well with a sample by mirror (Edmindoptics, #33–504) and focused with the lens (Thorlabs, AC254-045-A-ML) with a focal length of 45 mm, the observable size of the laser spot was around 80 μm. In addition, an optical filter was added to the system to cut off the secondary harmonic of the laser at 532 nm which otherwise resulted in noise in fluorescence signal. The control of the duration of laser flash and the time of its appearance was carried out through the usage of an Arduino Nano board that was connected through to the PC and the laser control unit. The board acts as impulse generator with the frequency of 2 kHz, which triggers laser pulses. The duration of the pulse tray is controlled by a PC operator. In our experiments, the duration was 200 ms, which was sufficient for the uncaging of ADP and platelet activation.

As a result, the following experiment was performed (Fig 1). Samples were placed on the scanning table of the microscope and rested for 5 minutes until the cells settled. The recording of the video with a frame rate of 3 fps began and approximately a minute after laser flash provokes photodissociation of caged ADP so the released ADP diffuses and triggers the platelet activation. The duration of the received video was around 3 to 4 minutes.

Fig 1. Scheme of the experimental setup.

Fig 1

Pulsed laser with the wavelength of 355 nm is directed to the experimental sample containing platelets with photolabile caged ADP. The laser is enabled for a computer-controlled duration, inducing release of active ADP and platelet activation, which is monitored with fluorescence microscope using Fluo-4 calcium probe.

Treatment of experimental data

Analysis of the recorded video was performed using the ImageJ (FiJi) software. To calculate the mean fluorescence signal versus time in the areas of interest, we used standard procedure utilizing ROI manager and the multi-measure feature. For the analysis of single cells, TrackMate plugin was used [32]. It allows one to automatically detect cells and provides the average intensities over time even if the cells are moving. The obtained results (coordinates and mean fluorescence intensity for each platelet) was saved and used in a custom Python script, which was needed for the determination of calcium spikes. Calcium spikes were determined using the standard peak detection function from the SciPy library. As a result, we were able to obtain the time of first calcium spike as a function of coordinates, which is needed for the validation of theoretical model.

Mathematical model of the platelet population response to agonist

The interaction between the platelets and agonists results in the activation response. This process can be considered as a switch from resting to activated state when the concentration of agonist exceeds certain threshold. The state switch triggers a cascade of biochemical reactions leading to the changes in the intracellular calcium concentration. To simulate the cellular response, we developed an algorithm that allows to predict the fraction of activated platelets over time in complex environment with inhomogeneous distribution of agonist.

The outline of the algorithm is shown in the Fig 2A for the case of two spatial dimensions. It is based on the assumption that all platelets are uniformly distributed on the area of interest and the sensitivity threshold TR belongs to the log-normal distribution:

TRlogNTR;μ,σ2, (1)

where

LogNμ,σ2=12πσxexp-(lnx-μ)22σ2 (2)

and x is the threshold value.

Fig 2. Simulation of diffusion-derived platelet activation.

Fig 2

A. Scheme of the algorithm. B. Simulated platelets just after the localized activation stimulus: each dot represents single cell, the red ones are activated platelets and the green ones are non-activated. C. The same after 50 sec of the stimulus onset, showing the diffusion-mediated spread of the area of activated cells.

The computation starts with initialization of cells. Typically, thousands of platelets are randomly placed in the area of interest, each having their own coordinates (xi,yi) and the ADP sensitivity threshold TRi. We presume that the displacement of platelets is insignificant and their size is small compared to characteristic scale of ADP concentration change; therefore, all the objects are considered immobile and point-like.

Next, the algorithm takes the ADP concentration profile ADP(x,y,t) as an input and compares the local ADP value for each platelet with the threshold TRi. The comparison is made sequentially in time. Initially, all platelets are considered to be in resting state and they become activated when the condition ADP(xi,yi,t) > TRi is met for the first time. Thus, the algorithm determines the moment of activation for each simulated platelet, which we designate as TAi.

Fig 2B, 2C show the example of the graphical representation of the results: each dot represents a platelet; the red ones correspond to the activated cells and the green ones are non-activated. All cells can be sorted by area, for instance, to determine the fraction of activated cells in the specific area of interest.

In this paper, we compare the theoretical prediction with experimental measurements of platelets intracellular calcium. Previous experiments showed that there is a delay (lag time) between the trigger pulse and the first calcium spike, which is distributed log-normally [33]. Therefore, to calculate the time of the first calcium spike TSi, additional delay TDi should be added to the activation time:

TSi=TAi+TDi, (3)

where TDi belongs to the log-normal distribution with parameters μD,σD:

TDLogNμD,σD2. (4)

ADP diffusion model

In this study, ADP is used to trigger platelet activation. The agonist is released from its caged analogue by the laser pulse. Since the laser beam has Gaussian intensity profile, we decided that the equations that describe the diffusion of a two-dimensional Gaussian peak [34] can be applied for the ADP concentration profiles:

[ADP]=ADP0t0t+t0expr24Dt+t0 (5)

where ADP0 is the initial concentration of a released agonist in the sample, D is the diffusion coefficient, t is the time since the system’s excitation, r is the distance from the excitation center and t0 is the characteristic time defined from the Gaussian distribution so that the distribution width at t = 0 matches the width of the laser beam.

Results

The following procedure was used to estimate the effect of ADP diffusion on the platelet activation. Firstly, platelets were prepared as described in Methods section. Secondly, the samples were placed on the experimental set up (Fig 1) and the videos were recorded. The examples of received frames are shown in Fig 3A–3D. Each platelet is represented as a glowing dot due to a fluorescence of the calcium probe showing a baseline level of intracellular calcium. After recording of ~60s of the resting sample, a laser flash was applied to the central region of the frame as showed in Fig 3B. This triggers a photorelease of ADP from its “caged” analogue inside the circle. The figure also shows the concentric circular areas with widening diameter which were used for later analysis to measure mean fluorescent signals over time. The diameter of the central circle is 108 μm, while the thickness of the other areas is 36 μm. Mean fluorescence signal rapidly increased near the irradiation circle due to platelet activation, as shown in Fig 3C. The area in which platelets are activated expands due to the diffusion of ADP; Fig 3C shows the frame after 10 s after irradiation, whereas Fig 3D shows the frame after 40s.

Fig 3. Dynamics of activation spreading.

Fig 3

A. Resting platelets before the stimulus. B. Initiation of ADP’s photorelease via the laser irradiation. Enumerated circles outline the regions in which fluorescent signals were measured. C. 10 seconds after the appearance of laser flash. Increasing in fluorescence levels of platelets that were nearby exposed area are visible whereas there are no changes in distant regions. D. 40 seconds after the appearance of laser flash. Spreading of activation due to the diffusion of ADP is visible. E-J. Calcium dynamics in representative cells from corresponding marked areas (areas 1 to 6 in panel B, respectively). Dashed line across all graphs represents the time when laser flash was applied. The exposure time is 1/3 s.

Fig 3E–3J represent typical single-cell calcium signaling in representative platelets. Rapid spikes with further decrease indicate the activation response, as observed in classical studies [13, 35]. Some platelets were spontaneously activated before the ADP uncaging, but the majority of cells were stable before the laser irradiation. The general tendency is clearly visible: platelets from the area nearest to the irradiation spot activate much faster than that from more distant areas. In Fig 3E the calcium spikes occur several seconds after the laser flash, while in subsequent plots the shift becomes larger: in Fig 3J the response delay is more than 20 s.

Fig 4A shows how the ADP concentration profiles change over time due to the diffusion according to Eq (5). The initial concentration of the released ADP was estimated with the high-performance liquid chromatography (HPLC) to be ADP0 = 1.5·10−5 M, whereas the initial width of the Gaussian corresponds to the width of the laser beam which was determined from video.

Fig 4. Spatiotemporal ADP concentration profiles.

Fig 4

A. Calculated ADP profile changes over time. B. The histogram of the activation time obtained in simulation. C. The histograms of the first spike time calculated for platelets in the corresponding areas. D. The fraction of activated platelets in simulation. E. The fraction of activated platelets in the experiment.

The concentration of ADP at the release point is much higher than at the periphery of the frame, but over time the ADP level in this area drops while increasing at distant points, which explains the delayed activation of cells. To quantify the activation time, we performed analysis of single-cell calcium response, looking for the first calcium spike after the laser flash. Fig 4C shows the distribution of the activation time (more precisely, the time of appearance of the first calcium spike TS, corresponding to Eq (3)) for four separate concentric areas. The appearance of platelets with delayed activation is visible as widening of the distribution to the right.

The mathematical model described in Methods, Eqs (1)–(4), allows us to simulate the platelet response to agonist given the time-dependent ADP concentration profile. To compare this model with experimental data, we used the ADP diffusion coefficient D = 257 μm2/s from [36].We assume that the activation time delay TA is negligible for the area nearest to the irradiation circle, which can be estimated according to the model and characteristic parameters of platelets; therefore, we were able to determine the parameters of the delay time TD by fitting of experimental histogram for this circle with log-normal distribution density similar to [33]. The obtained parameters are given in S1 Table in S1 File. The simulation results for N = 100000 platelets are shown in Fig 4B. Widening of the distributions for distant areas are also visible, which indicates the qualitative agreement with experimental findings. The fraction of activated platelets as a function of time is plotted in Fig 4D and 4E for theory and experiment, respectively. Although the overall results are in qualitative agreement, simulation predicts the lag-time in distant areas, which is absent in experiment.

Next, we applied our model to the analysis of mean fluorescence signals from the separate areas. In this case, we do not need to use single-cell tracking and analysis software but simply use the built-in “multi-measure” function of ImageJ. The primary processing of the experimental data includes few steps. Firstly, the initial data set is divided into 2 parts, before and after the laser flash. During the first part system is stabilizing and the rapid rise in the signal is observed after the laser flash. The data for each area was normalized to the intensity of initial signals (before the flash). Fig 5A, 5C and 5E shows the obtained data for three experiments (for each of three donors) with duration of irradiation of 200 ms and the concentration of the caged ADP of 0.375 mM. The signal growth is faster near the irradiation circle (black line) and slower at distant areas, displaying the diffusion-mediated delay.

Fig 5. Simulation of fluorescent signals.

Fig 5

A,C,E: Mean fluorescence intensity in the concentric circles around the laser beam (black curve–nearest circle, pink–the most distant circle) shown for three donors. B,D,F: The best-fit theoretical curves corresponding to the curves on the left part of the figure.

To simulate the fluorescence signals, we use only Eqs (1)–(2) because we do not need to analyze individual calcium spikes. Instead, we made the following simplification. While in experiment the mean signal is comprised by many calcium spikes which occurs in different cells at different times, in a simulation we consider each cell to contribute a smooth, growth-and-decay function to a total signal. This is justified because there are many cells in the areas under consideration and all spikes are well averaged; in other words, each “cell” in the simulation can be considered as an ensemble of many cells. The function itself is determined from experiment again using the area nearest to the irradiation circle, where the delay is considered to be negligible. We constructed a basic fluorescence intensity function by polynomial fit of the corresponding experimental time-dependence. Then the fluorescent signals in other areas are determined by the summation of the basic function shifted in time by TAi for all cells. Lastly, the obtained intensities are normalized by the number of cells simulated in the area.

Calculations were performed for N = 50000 simulated objects. In this case, we varied σ and μ to determine the best-fit parameters by a least square method (LSM) resulting in minimal discrepancy between experimental and simulated data. This approach could be useful for the estimation of platelets population sensitivity, which may have the diagnostic value. The obtained parameters for three donors are presented in the Table 1.

Table 1. The parameters of the platelet ADP threshold distribution for three healthy donors.

Donor, № μ σ ADP threshold, median (M) ADP threshold, mode (M)
1 (Fig 5A, 5B) -15.5 2.7 1.83·10−7 1.25·10−10
2 (Fig 5C, 5D) -13.2 2.7 1.88·10−6 1.43·10−9
3 (Fig 5E, 5F) -14.5 1.7 4.99·10−7 2.68·10−8

The obtained sensitivity parameters, namely the mode of distribution that is near 10−7 M, are in range of the previously published values, in particular, the platelet sensitivity parameter MPS-ADP which was determined in [31] by measuring the shape change. As it is shown on the best-fit approximation graphs (Fig 5B, 5D and 5F), the model predicts characteristic delays in distant areas as well as the decrease in fluorescence growth rate.

Discussion

In this paper, we present novel simplified model of platelet population spatiotemporal response on known agonist, ADP. The developed model is used for prediction of cellular threshold-like activation behavior on the surrounding microenvironment. It combines calculations of reaction time according to the spatiotemporal distribution of ADP and fluorescent signals for each simulated cell. Results showed qualitative correspondence of simulation with experimental data in the experiment of locally induced platelet activation. We assume that suggested approach can be utilized in large-scale models of thrombus growth. Furthermore, the received parameters of log-normal distribution that indicate the sensitivity of platelet population can be valuable as a diagnostic tool.

The described approach definitely has some limitations. First, the model is phenomenological and extremely simplified. It does not include any kinetic equations that describe biochemical machinery of signaling pathways, making it impossible to predict the shift in the model parameters and even its validity due upon the change in real-world variables. Second, as it was described earlier, we used the continuous smooth polynomial function for the simulation of calcium response for an ensemble of cells, which is inapplicable if the ensemble size is small because the calcium signaling in single cells consists of many stochastic spikes. This response is quite complicated because of unpredictability of spacing between calcium spikes and their amplitudes. As a result, we have to use experimental data as a model input–for instance, we used the histogram of response time TD in the single-cell experiments and mean calcium signal of platelets near the ADP source as a basic function for the description of cells’ ensemble response. On the other hand, this gives our model the ability to be used for the description of any experiments, not necessarily calcium response. The study of effects other than the calcium signaling might shed light in different aspects of platelet function. For instance, the activation of surface integrins, granule release and procoagulant surface formation can be visualized using special fluorescent labels [37]. The platelet shape change [38, 39] is also a sensitive marker of platelet activation. All these effects are also affected by the inhomogeneous distribution of agonist and follow the time-shift pattern of activation, which is predicted by our model.

Some divergence between the model and experimental data is caused by deliberate exclusion of some issues. First, we do not take into the account the positive feedback loop caused by the granule release [40] and crosstalk between signaling pathways. Although it is possible to estimate granule release in living cells [41], further interactions of granules with platelets as well as their impact on activation compared to the processes described in this paper are hard to predict. Second, we assume the presence of only activated and non-activated platelets in the sample. However, there also other types of cells such as partially activated platelets [42], aggregating platelets that are a strong source of molecules that boost procoagulant activity and procoagulant platelets which release inflammation mediators [43]. Lastly, the developed model for simplicity suggests identical activation response for all cells, while there should be a correlation between platelet sensitivity and the response speed and amplitude.

Further researches might cover the above-mentioned issues alongside with the determination of synergetic and inhibitory effects of multiple agonists. Our recent studies [44, 45], showed that the use of photo-generated nitric oxide (NO) inhibits spontaneous platelet activation, providing more physiological conditions in vitro. It is interesting to combine ADP with other photolabile compounds affecting platelet activation, such as caged epinephrine, arachidonic acid [46] and others, especially if they can be “uncaged” independently at different wavelengths. Further studies might broaden the understanding of platelet functions and help to find out the possible ways of treatment of cardiovascular diseases.

Supporting information

S1 File

(PDF)

pone.0308679.s001.pdf (438.8KB, pdf)
S1 Video

(MP4)

Download video file (54MB, mp4)
S1 Data

(ZIP)

pone.0308679.s003.zip (41.7MB, zip)
S2 Data

(GIF)

pone.0308679.s004.gif (10.9MB, gif)

Data Availability

All relevant data are within the manuscript and its Supporting Information files

Funding Statement

The study was supported by the Russian Science Foundation (grant #23-75-10049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Duerschmied D, Bode C, Ahrens I. Immune functions of platelets. Thromb Haemost. 2014;112: 678–691. doi: 10.1160/TH14-02-0146 [DOI] [PubMed] [Google Scholar]
  • 2.Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22: 1276–1312. doi: 10.1101/gad.1653708 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Battinelli EM. 24 ‐ The Role of Platelets in Angiogenesis. In: Michelson AD, editor. Platelets (Fourth Edition). Academic Press; 2019. pp. 433–441. doi:10.1016/B978-0-12-813456-6.00024–2
  • 4.Moskalensky AE, Yurkin MA, Muliukov AR, Litvinenko AL, Nekrasov VM, Chernyshev AV, et al. Method for the simulation of blood platelet shape and its evolution during activation. PLOS Computational Biology. 2018;14: e1005899. doi: 10.1371/journal.pcbi.1005899 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Broos K, Feys HB, De Meyer SF, Vanhoorelbeke K, Deckmyn H. Platelets at work in primary hemostasis. Blood Reviews. 2011;25: 155–167. doi: 10.1016/j.blre.2011.03.002 [DOI] [PubMed] [Google Scholar]
  • 6.Brass LF, Diamond SL, Stalker TJ. Platelets and hemostasis: a new perspective on an old subject. Blood Advances. 2016;1: 5–9. doi: 10.1182/bloodadvances.2016000059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Willoughby S, Holmes A, Loscalzo J. Platelets and cardiovascular disease. European Journal of Cardiovascular Nursing. 2002. doi: 10.1016/s1474-5151(02)00038-5 [DOI] [PubMed] [Google Scholar]
  • 8.Lee MY, Diamond SL. A Human Platelet Calcium Calculator Trained by Pairwise Agonist Scanning. PLoS Comput Biol. 2015;11: e1004118. doi: 10.1371/journal.pcbi.1004118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gachet C. P2Y12 receptors in platelets and other hematopoietic and non-hematopoietic cells. Purinergic Signalling. 2012;8: 609–619. doi: 10.1007/s11302-012-9303-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Li Z, Delaney MK, O’Brien KA, Du X. Signaling During Platelet Adhesion and Activation. Arteriosclerosis, Thrombosis, and Vascular Biology. 2010;30: 2341–2349. doi: 10.1161/ATVBAHA.110.207522 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Varga‐szabo D, Braun A, Nieswandt B. Calcium signaling in platelets. Journal of Thrombosis and Haemostasis. 2009;7: 1057–1066. doi: 10.1111/j.1538-7836.2009.03455.x [DOI] [PubMed] [Google Scholar]
  • 12.Gee KR, Brown KA, Chen W-NU, Bishop-Stewart J, Gray D, Johnson I. Chemical and physiological characterization of fluo-4 Ca2+-indicator dyes. Cell Calcium. 2000;27: 97–106. doi: 10.1054/ceca.1999.0095 [DOI] [PubMed] [Google Scholar]
  • 13.Heemskerk JWM, Willems GM, Rook MB, Sage SO. Ragged spiking of free calcium in ADP-stimulated human platelets: regulation of puff-like calcium signals in vitro and ex vivo. J Physiol. 2001;535: 625–635. doi: 10.1111/j.1469-7793.2001.00625.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Shakhidzhanov SS, Shaturny VI, Panteleev MA, Sveshnikova AN. Modulation and pre-amplification of PAR1 signaling by ADP acting via the P2Y12 receptor during platelet subpopulation formation. Biochim Biophys Acta. 2015;1850: 2518–2529. doi: 10.1016/j.bbagen.2015.09.013 [DOI] [PubMed] [Google Scholar]
  • 15.Yun S-H, Sim E-H, Goh R-Y, Park J-I, Han J-Y. Platelet Activation: The Mechanisms and Potential Biomarkers. BioMed Research International. 2016;2016: e9060143. doi: 10.1155/2016/9060143 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.McNicol A, Israels SJ. Platelet Dense Granules. Thrombosis Research. 1999;95: 1–18. doi: 10.1016/S0049-3848(99)00015-8 [DOI] [PubMed] [Google Scholar]
  • 17.Charo IF, Feinman RD, Detwiler TC. Interrelations of Platelet Aggregation and Secretion. American Society for Clinical Investigation; 1 Oct 1977. [cited 25 Dec 2023]. doi: 10.1172/JCI108841 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hardisty RM, Hutton RA, Montgomery D, Rickard S, Trebilcock H. Secondary Platelet Aggregation: A Quantitative Study. Br J Haematol. 1970;19: 307–319. doi: 10.1111/j.1365-2141.1970.tb01628.x [DOI] [PubMed] [Google Scholar]
  • 19.Purvis JE, Chatterjee MS, Brass LF, Diamond SL. A molecular signaling model of platelet phosphoinositide and calcium regulation during homeostasis and P2Y1 activation. Blood. 2008;112: 4069–4079. doi: 10.1182/blood-2008-05-157883 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Sveshnikova AN, Ataullakhanov FI, Panteleev MA. Compartmentalized calcium signaling triggers subpopulation formation upon platelet activation through PAR1. Mol BioSyst. 2015;11: 1052–1060. doi: 10.1039/c4mb00667d [DOI] [PubMed] [Google Scholar]
  • 21.Jackson SP, Nesbitt WS, Westein E. Dynamics of platelet thrombus formation. Journal of Thrombosis and Haemostasis. 2009;7: 17–20. doi: 10.1111/j.1538-7836.2009.03401.x [DOI] [PubMed] [Google Scholar]
  • 22.Du J, Kim D, Alhawael G, Ku DN, Fogelson AL. Clot Permeability, Agonist Transport, and Platelet Binding Kinetics in Arterial Thrombosis. Biophysical Journal. 2020;119: 2102–2115. doi: 10.1016/j.bpj.2020.08.041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Alkhamis TM, Alma’atah BM. Evaluation of Red Blood Cell Contribution to Platelet Activation in the Bulk Applying Red Blood Cell—Platelet Thrombus as a Point Source Model. Advances in Bioscience and Biotechnology. 2022;13: 92–111. doi: 10.4236/abb.2022.132004 [DOI] [Google Scholar]
  • 24.Tomaiuolo M, Brass LF, Stalker TJ. Regulation of Platelet Activation and Coagulation and Its Role in Vascular Injury and Arterial Thrombosis. Interventional Cardiology Clinics. 2017;6: 1–12. doi: 10.1016/j.iccl.2016.08.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Link KG, Sorrells MG, Danes NA, Neeves KB, Leiderman K, Fogelson AL. A Mathematical Model of Platelet Aggregation in an Extravascular Injury Under Flow. Multiscale Model Simul. 2020;18: 1489–1524. doi: 10.1137/20m1317785 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Cardillo G, Barakat AI. A computational model of chemically and mechanically induced platelet plug formation. 2023. [cited 17 Jul 2024]. doi: 10.1101/2023.01.26.525741 [DOI] [Google Scholar]
  • 27.Shankar KN, Zhang Y, Sinno T, Diamond SL. A three-dimensional multiscale model for the prediction of thrombus growth under flow with single-platelet resolution. PLoS Comput Biol. 2022;18: e1009850. doi: 10.1371/journal.pcbi.1009850 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Shankar KN, Diamond SL, Sinno T. Development of a parallel multiscale 3D model for thrombus growth under flow. Front Phys. 2023;11. doi: 10.3389/fphy.2023.1256462 [DOI] [Google Scholar]
  • 29.Tokarev A, Sirakov I, Panasenko G, Volpert V, Shnol E, Butylin A, et al. Continuous mathematical model of platelet thrombus formation in blood flow. Russian Journal of Numerical Analysis and Mathematical Modelling. 2012;27: 191–212. doi: 10.1515/rnam-2012-0011 [DOI] [Google Scholar]
  • 30.Belyaev AV, Dunster JL, Gibbins JM, Panteleev MA, Volpert V. Modeling thrombosis in silico: Frontiers, challenges, unresolved problems and milestones. Physics of Life Reviews. 2018;26–27: 57–95. doi: 10.1016/j.plrev.2018.02.005 [DOI] [PubMed] [Google Scholar]
  • 31.Litvinenko AL, Nekrasov VM, Strokotov DI, Moskalensky AE, Chernyshev AV, Shilova AN, et al. Blood platelet quantification by light scattering: from morphology to activation. Anal Methods. 2021;13: 3233–3241. doi: 10.1039/d1ay00431j [DOI] [PubMed] [Google Scholar]
  • 32.Tinevez J-Y, Perry N, Schindelin J, Hoopes GM, Reynolds GD, Laplantine E, et al. TrackMate: An open and extensible platform for single-particle tracking. Methods. 2017;115: 80–90. doi: 10.1016/j.ymeth.2016.09.016 [DOI] [PubMed] [Google Scholar]
  • 33.Spiryova DV, Vorobev AYu, Klimontov VV, Koroleva EA, Moskalensky AE. Optical uncaging of ADP reveals the early calcium dynamics in single, freely moving platelets. Biomed Opt Express. 2020;11: 3319. doi:10.1364/BOE.392745 [DOI] [PMC free article] [PubMed]
  • 34.Malone CM, Nonaka A, Almgren AS, Bell JB, Zingale M. MULTIDIMENSIONAL MODELING OF TYPE I X-RAY BURSTS. I. TWO-DIMENSIONAL CONVECTION PRIOR TO THE OUTBURST OF A PURE 4 He ACCRETOR. ApJ. 2011;728: 118. doi: 10.1088/0004-637X/728/2/118 [DOI] [Google Scholar]
  • 35.Obydennyy SI, Sveshnikova AN, Ataullakhanov FI, Panteleev MA. Dynamics of calcium spiking, mitochondrial collapse and phosphatidylserine exposure in platelet subpopulations during activation. J Thromb Haemost. 2016;14: 1867–1881. doi: 10.1111/jth.13395 [DOI] [PubMed] [Google Scholar]
  • 36.Kirby P, Buerk DG, Parikh J, Barbee KA, Jaron D. Mathematical Model for Shear Stress Dependent NO and Adenine Nucleotide Production from Endothelial Cells. Nitric Oxide. 2016;52: 1–15. doi: 10.1016/j.niox.2015.10.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Linden MD. Platelet Flow Cytometry. In: Monagle P, editor. Haemostasis: Methods and Protocols. Totowa, NJ: Humana Press; 2013. pp. 241–262. doi:10.1007/978-1-62703-339-8_18
  • 38.Chung J, Jeong D, Kim G, Go S, Song J, Moon E, et al. Super-resolution imaging of platelet-activation process and its quantitative analysis. Sci Rep. 2021;11: 10511. doi: 10.1038/s41598-021-89799-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Moskalensky A, Litvinenko A. The platelet shape change: biophysical basis and physiological consequences. Platelets. doi: 10.1080/09537104.2018.1514109 [DOI] [PubMed] [Google Scholar]
  • 40.Holinstat M. Normal platelet function. Cancer Metastasis Rev. 2017;36: 195–198. doi: 10.1007/s10555-017-9677-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Westmoreland D, Shaw M, Grimes W, Metcalf DJ, Burden JJ, Gomez K, et al. Super‐resolution microscopy as a potential approach to diagnosis of platelet granule disorders. Journal of Thrombosis and Haemostasis. 2016;14: 839–849. doi: 10.1111/jth.13269 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Litvinenko AL, Moskalensky AE, Karmadonova NA, Nekrasov VM, Strokotov DI, Konokhova AI, et al. Fluorescence-free flow cytometry for measurement of shape index distribution of resting, partially activated, and fully activated platelets. Cytometry A. 2016;89: 1010–1016. doi: 10.1002/cyto.a.23003 [DOI] [PubMed] [Google Scholar]
  • 43.Chu Y, Guo H, Zhang Y, Qiao R. Procoagulant platelets: Generation, characteristics, and therapeutic target. Journal of Clinical Laboratory Analysis. 2021;35: e23750. doi: 10.1002/jcla.23750 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Panfilov M, Karogodina T, Sibiryakova A, Tretyakova I, Vorob’ev A, Moskalensky A. Meso-Aminomethyl-BODIPY as a Scaffold for Nitric Oxide Photo-Releasers. ChemRxiv; 2023. doi: 10.26434/chemrxiv-2022-m2z57-v2 [DOI] [Google Scholar]
  • 45.Zhermolenko EO, Karogodina TYu, Vorobev AYu, Panfilov MA, Moskalensky AE. Photocontrolled release of nitric oxide for precise management of NO concentration in a solution. Materials Today Chemistry. 2023;29: 101445. doi:10.1016/j.mtchem.2023.101445
  • 46.Litunenko DN, Karogodina TY, Vorob’ev AY, Moskalensky AE. Novel UV-Releaser of Arachidonic Acid Based on Nitrophenyl-type Photoremovable Protecting Group. Journal of Biomedical Photonics & Engineering. 2022;8: 030305. doi: 10.18287/JBPE22.08.030305 [DOI] [Google Scholar]
PLoS One. 2024 Oct 3;19(10):e0308679. doi: 10.1371/journal.pone.0308679.r001

Author response to previous submission


Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

8 Apr 2024

Attachment

Submitted filename: PLOS_reviewers Ezh.pdf

pone.0308679.s005.pdf (400.4KB, pdf)

Decision Letter 0

Heather Faith Pidcoke

7 Jun 2024

PONE-D-24-12691Platelet activation near point-like source of agonist: theoretical model and experimental verificationPLOS ONE

Dear Dr. Moskalensky,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The reviewers have provided incisive and valuable feedback that needs to be addressed in its entirety for publication in PLOS ONE. Please note that both reviewers took exception to the statement in the abstract that “...existing models are too complicated for large-scale problems, for instance, simulation of the thrombus growth, where the concentration of agonist varies significantly and heterogeneity of platelets should be taken into account.” Please ensure that in addition to addressing the remaining comments, that you address this statement and cite publications that solve for thrombus growth with agonist gradients and individual platelets.

Please submit your revised manuscript by Jul 22 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Heather Faith Pidcoke, MD, MSCI, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure: 

"The study was supported by the Russian Science Foundation (grant #23-75-10049)."

Please state what role the funders took in the study.  If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Authors study a novel system of photo-released ADP and platelet activation in space and time. The experiments and data analysis are conducted with care.

Major comments.

The paper does not appear to include conditions where agonist induced ADP release and thromboxane synthesis play an autocrinic role. Authors are encouraged to find conditions of platelet density, P2Y12 inhibitors, or COX1 inhibitors that may modulate the spread of platelet activation. Are there conditions where platelet release of ADP causes a self-sustaining wave of calcium activation, distinct from the diffusional spread of photo-released ADP. As a thrombus grows, the platelet density is very high and autocrine activation definitely occurs.

The authors should discuss the role of geometry and platelet density. The height of the liquid determines the size of the reaction volume and the amount of photo-released ADP. Different results would be obtained in different geometries such as activation of a cross section of a tubular geometry or rectangular geometry (as in microfluidics).

Phosphate buffer will cause calcium to precipitate. The studies should be repeated with HEPES buffered saline. (Tris should be avoided since it has anti-protease activity in coagulation studies).

The authors should provide evidence that the platelets have settled to the bottom of the well. If the platelets have spread then they are partially activated before the laser is used.

Minor Comments:

Abstract: “However, existing models are too complicated for

large-scale problems, for instance, simulation of the thrombus growth, where the

concentration of agonist varies significantly and heterogeneity of platelets should be

taken into account.” This statement is not correct. There are several publications that solve for thrombus growth with agonist gradients and individual platelets.

Reviewer #2: The manuscript reports a study of platelet activation by a point source of ADP. The Authors designed an experimental setup and developed a mathematical model for spatio-temporal dynamics of the diffusion-mediated spread of the area of activated cells. The Materials and Methods are detailed enough to allow the reproducibility of the results. The Authors replied all the remarks from the previous round of peer-review, even added new experiments with healthy donors, as was required by the Reviewer #1.

1. The paper in written in standard English, however, some typos are present, e.g., on page 2, line 13 - "Biochemical cascade of the platelet activation involve special" - should be "involves".

2. In the PDF version of the manuscript some equations (e.g. 1 and 2) are not displayed properly, although in the docx-file the equations are readable. This should be elaborated during the publication process in case of acceptance.

3. The Authors "presumed that the displacement of the platelets as well as their size is insignificant". I can agree that this assumption is somehow valid in terms of the displacement. However, the independence of the activation threshold (minimal ADP concentration) from platelet size should be substantiated, as it is not obvious. Could there be a correlation between the ADP-threshold and platelet size? Some references suggest that platelet volume may be a risk marker for platelet activation:

https://doi.org/10.1080/095371002220148332

https://doi.org/10.1093/rheumatology/kew437

4. Fig.3. In the caption it should be explicitly mentioned that panels E-J correspond to the areas 1-6 marked on the panel B.

5. The Authors claim that existing mathematical approaches are too complicated to be used in systems biology models. But in my opinion their model oversimplifies the picture. Generally, the paper tells us that the diffusion of ADP activates the platelets. The model is based on the solution of the diffusion equation (Fick's law) and the probabilistic distribution of platelet susceptibility to ADP. This finding does not reveal any new biophysics mechanism, nor it incorporates already known features into the suggested model, such as granule release and positive feedback loops. In my opinion, the paper is valuable for its experimental part (as the results seem rigorous), while the proposed model is essentially phenomenological and it doesn't enhance our understanding of platelet activation.

Therefore, I suggest to modify the title: the experimental part should brought forward, while the theoretical model is subsidiary. The fact that the theory "captures main features of experiment (activation spread) but cannot accurately describe other features" mainly says that the model is not precise enough, as it doesn't account for possible nonlinear effects and feed-back loops, which are essential for such an active medium. Clearly, the spreading of "platelet activation" in not entirely governed by the diffusion, although the diffusion of ADP indeed triggers the observed processes.

I also suggest to remove the phrase "detailed models require too much computational resources for the use in large-scale simulations" on page 3. Existing models are indeed complex, but this is done for a reason: for a correct biophysical description of the phenomenon and thus correct spatio-temporal dynamics of platelet activation.

6. On page 10, "simulation predicts the lag-time in distant areas, which is absent in experiment, probably indicating the presence of extra-sensitive platelets". This hypothesis is speculative, I suggest to remove "probably indicating the presence of extra-sensitive platelets" from the text, unless the Authors can substantiate it.

7. Fig.4(B,C). What variables correspond to the digits along the axes? (D,E) Same issue for the vertical axis.

Overall, I can agree with the Reviewer#2 that this paper is not suitable for PLOS Computational Biology. Clearly, it is true that "more work is needed to substantiate the conclusions of novelty and applicability in the manuscript". I also agree with the Authors that the modifications and the additional work that they have done make the manuscript suitable for PLOS ONE, as it accepts scientifically rigorous research, regardless of novelty. But the concerns mentioned above must be addressed before acceptance.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Oct 3;19(10):e0308679. doi: 10.1371/journal.pone.0308679.r003

Author response to Decision Letter 0


17 Jul 2024

We thank the reviewers for their constructive comments. Our answers are below.

Reviewer #1:

Authors study a novel system of photo-released ADP and platelet activation in space and time. The experiments and data analysis are conducted with care.

Major comments.

The paper does not appear to include conditions where agonist induced ADP release and thromboxane synthesis play an autocrinic role. Authors are encouraged to find conditions of platelet density, P2Y12 inhibitors, or COX1 inhibitors that may modulate the spread of platelet activation. Are there conditions where platelet release of ADP causes a self-sustaining wave of calcium activation, distinct from the diffusional spread of photo-released ADP. As a thrombus grows, the platelet density is very high and autocrine activation definitely occurs.

We agree with the reviewer that autocrine (and paracrine) activation plays significant role in the thrombus growth. Moreover, our motivation and primary goal for the described experiments was to observe the self-sustaining wave of calcium activation. Unfortunately, in our experimental conditions there is no evidence for autocrine activation, and the simplest model of ADP-diffusion–mediated activation is consistent with the experimental data. We agree that it would be very interesting to find experimental conditions where the autocrine activation is directly visible, but we have not succeeded in this to date and should leave it for the future research.

The authors should discuss the role of geometry and platelet density. The height of the liquid determines the size of the reaction volume and the amount of photo-released ADP. Different results would be obtained in different geometries such as activation of a cross section of a tubular geometry or rectangular geometry (as in microfluidics).

The height of the liquid in each sample was 2 mm (we have indicated this into the Mat&Meth section). This is smaller than the laser spot waist length (Rayleigh length), which is 3.5 mm. Therefore, in these conditions the system can be considered two-dimensional, i.e. the laser intensity is independent on the vertical coordinate.

On the other hand, the width of the sample is 7 mm, which is much larger than the width of the laser spot (20 microns) and the size of the zone where the activation occurs. It means that in our conditions the boundaries have no impact on the process.

Indeed, as the Reviewer indicates, different results could be obtained in different geometries if the boundaries would be close to the activation spot, which can be true in the case of microfluidics.

Phosphate buffer will cause calcium to precipitate. The studies should be repeated with HEPES buffered saline. (Tris should be avoided since it has anti-protease activity in coagulation studies).

As the reviewer suggested, we performed additional experiments to compare the effect of two buffers, PBS and HEPES. Interestingly, no activation was observed when using HEPES buffer, whereas in the same experiment with PBS the effect was clearly visible. On the other hand, platelets looked brighter in HEPES solution. While the cause of this result is not completely clear, on the current stage we stick to using PBS as the change of buffering system would require additional experiments. The results of the comparison experiment are shown in the Supplementary materials, Figure S3. We also added a reference to these results to the Mat&Meth section.

The authors should provide evidence that the platelets have settled to the bottom of the well. If the platelets have spread then they are partially activated before the laser is used.

We agree with the Reviewer that spread platelets are partially activated prior to the experiment. Such cells are indeed visible in some experiments as a background noise. However, the majority of platelets are chaotically moving during the experiment (as can be seen in Supplementary videos), which means that they are not attached to the bottom of the well.

Minor Comments:

Abstract: “However, existing models are too complicated for

large-scale problems, for instance, simulation of the thrombus growth, where the

concentration of agonist varies significantly and heterogeneity of platelets should be

taken into account.” This statement is not correct. There are several publications that solve for thrombus growth with agonist gradients and individual platelets.

The term “existing models” in the sentence refers to the detailed biochemical models of platelet activation such as described by Purvis et al (https://doi.org/10.1182/blood-2008-05-157883 ). We corrected the text in the abstract. We also added references to several publications concerning thrombus growth simulation into the introduction.

Reviewer #2

The manuscript reports a study of platelet activation by a point source of ADP. The Authors designed an experimental setup and developed a mathematical model for spatio-temporal dynamics of the diffusion-mediated spread of the area of activated cells. The Materials and Methods are detailed enough to allow the reproducibility of the results. The Authors replied all the remarks from the previous round of peer-review, even added new experiments with healthy donors, as was required by the Reviewer #1.

1. The paper in written in standard English, however, some typos are present, e.g., on page 2, line 13 - "Biochemical cascade of the platelet activation involve special" - should be "involves".

Fixed.

2. In the PDF version of the manuscript some equations (e.g. 1 and 2) are not displayed properly, although in the docx-file the equations are readable. This should be elaborated during the publication process in case of acceptance.

This issue seems to be related to the online docx -> pdf conversion system.

3. The Authors "presumed that the displacement of the platelets as well as their size is insignificant". I can agree that this assumption is somehow valid in terms of the displacement. However, the independence of the activation threshold (minimal ADP concentration) from platelet size should be substantiated, as it is not obvious. Could there be a correlation between the ADP-threshold and platelet size? Some references suggest that platelet volume may be a risk marker for platelet activation:

https://doi.org/10.1080/095371002220148332

https://doi.org/10.1093/rheumatology/kew437

In the mentioned sentence, size was assumed to be negligible compared to the ADP change scale. We have changed the sentence as follows:

We presume that the displacement of platelets as well as their size is insignificant and their size is small compared to characteristic scale of ADP concentration change; therefore, all the objects are considered immobile and point-like.

4. Fig.3. In the caption it should be explicitly mentioned that panels E-J correspond to the areas 1-6 marked on the panel B.

Fixed.

5. The Authors claim that existing mathematical approaches are too complicated to be used in systems biology models. But in my opinion their model oversimplifies the picture. Generally, the paper tells us that the diffusion of ADP activates the platelets. The model is based on the solution of the diffusion equation (Fick's law) and the probabilistic distribution of platelet susceptibility to ADP. This finding does not reveal any new biophysics mechanism, nor it incorporates already known features into the suggested model, such as granule release and positive feedback loops. In my opinion, the paper is valuable for its experimental part (as the results seem rigorous), while the proposed model is essentially phenomenological and it doesn't enhance our understanding of platelet activation.

Therefore, I suggest to modify the title: the experimental part should brought forward, while the theoretical model is subsidiary. The fact that the theory "captures main features of experiment (activation spread) but cannot accurately describe other features" mainly says that the model is not precise enough, as it doesn't account for possible nonlinear effects and feed-back loops, which are essential for such an active medium. Clearly, the spreading of "platelet activation" in not entirely governed by the diffusion, although the diffusion of ADP indeed triggers the observed processes.

We suggest the following title:

Platelet activation near point-like source of agonist: experimental insights and computational model.

I also suggest to remove the phrase "detailed models require too much computational resources for the use in large-scale simulations" on page 3. Existing models are indeed complex, but this is done for a reason: for a correct biophysical description of the phenomenon and thus correct spatio-temporal dynamics of platelet activation.

We have removed the phrase.

6. On page 10, "simulation predicts the lag-time in distant areas, which is absent in experiment, probably indicating the presence of extra-sensitive platelets". This hypothesis is speculative, I suggest to remove "probably indicating the presence of extra-sensitive platelets" from the text, unless the Authors can substantiate it.

We have removed the phrase.

7. Fig.4(B,C). What variables correspond to the digits along the axes? (D,E) Same issue for the vertical axis.

We have added the corresponding descriptions of the axes.

Overall, I can agree with the Reviewer#2 that this paper is not suitable for PLOS Computational Biology. Clearly, it is true that "more work is needed to substantiate the conclusions of novelty and applicability in the manuscript". I also agree with the Authors that the modifications and the additional work that they have done make the manuscript suitable for PLOS ONE, as it accepts scientifically rigorous research, regardless of novelty. But the concerns mentioned above must be addressed before acceptance.

Attachment

Submitted filename: PLOS One Response.pdf

pone.0308679.s006.pdf (100.3KB, pdf)

Decision Letter 1

Heather Faith Pidcoke

30 Jul 2024

Platelet activation near point-like source of agonist: experimental insights and computational model

PONE-D-24-12691R1

Dear Dr. Moskalensky,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Heather Faith Pidcoke, MD, MSCI, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Heather Faith Pidcoke

2 Aug 2024

PONE-D-24-12691R1

PLOS ONE

Dear Dr. Moskalensky,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Heather Faith Pidcoke

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (PDF)

    pone.0308679.s001.pdf (438.8KB, pdf)
    S1 Video

    (MP4)

    Download video file (54MB, mp4)
    S1 Data

    (ZIP)

    pone.0308679.s003.zip (41.7MB, zip)
    S2 Data

    (GIF)

    pone.0308679.s004.gif (10.9MB, gif)
    Attachment

    Submitted filename: PLOS_reviewers Ezh.pdf

    pone.0308679.s005.pdf (400.4KB, pdf)
    Attachment

    Submitted filename: PLOS One Response.pdf

    pone.0308679.s006.pdf (100.3KB, pdf)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES